The MOHW promised to operate a system that does not cause damage to patients due to the suspension of high-priced anticancer drug benefits due to the expansion of the new comprehensive insurance system. The plan is to review and operate measures to ensure continuity of treatment for existing patients taking expensive anticancer drugs such as Keytruda.

On the 1st, the MOHW expressed this position when Nam In-soon of the Democratic Party of Korea and Kang Byung-won pointed out.

The two lawmakers raised the issue that insurance benefits for patients who take expensive anticancer drugs were suddenly suspended in the process of improving the new comprehensive fee system by the MOHW. The intent